Following this year’s South by Southwest (SXSW) conference in Austin, Texas, it occurred to me that the progression of SXSW matches what I’ve seen – and
The FDA has approved Akebia Therapeutics’ vadadustat as a treatment for anaemia caused by chronic kidney disease (CKD) in dialysis patients, becoming the first rival to GS